CAMRIS International, Inc.

What CAMRIS International, Inc. does

CAMRIS International, Inc. is a Bethesda, Maryland-based federal government contractor that delivers adaptive scientific, technical, and program management services to U.S. Department of Defense and civilian health agencies. Founded in 1997 and operating as a wholly-owned subsidiary of the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), the company is organized around two primary service lines — Military Health & Research and Clinical & Life Sciences — covering military operational medicine, clinical and rehabilitative medicine, military population health, infectious disease research, laboratory services, biomanufacturing, vaccine and immunological research, clinical trials, and grants/program management. Its core technology stack includes BSL-2/3/3AG/4 containment laboratories, a Beckman Coulter i7 high-throughput immunoassay automation platform, bioinformatics and systems biology pipelines, and the $90M, 10-year Pilot Bioproduction Facility (PBF) at Walter Reed Army Institute of Research, which provides CDMO services for mRNA vaccines, monoclonal antibodies, viral vectors, and microbial biologics.

CAMRIS generates revenue by competing for task orders under multiple pre-negotiated indefinite delivery/indefinite quantity (IDIQ) vehicles, including the Defense Health Agency OMNIBUS IV, GSA Multiple Award Schedule, OASIS+ Unrestricted, and NIH/NIAID Professional, Scientific and Technical Support Services. Pricing is not publicly disclosed and is established at the task-order level. Customer concentration is high and skewed toward U.S. military health buyers — WRAIR, NIAID, DHA, NHRC, and NMRC — with reported operational experience spanning more than 100 countries and 60+ infectious diseases. The company differentiates on cleared, advanced-degree staff, embedded long-duration program positions, and specialized containment and biomanufacturing infrastructure that federal agencies can access rapidly through existing contract vehicles.

Name

CAMRIS International, Inc.

Legal name

CAMRIS International, Inc.

Website

https://camris.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

CAMRIS International is a Bethesda-based federal contractor and HJF subsidiary that provides biomedical research, clinical trials, biomanufacturing, and program management services to U.S. military health and civilian health agencies under IDIQ contract vehicles.

Ownership category

akta.pro rank

Product category

Federal Government R&D and Technical Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

akta.pro secondary industry

Defense Acquisition, Procurement & Contracting (BPAIAHAB)

Keywords

• Federal government contracting
• Military health research
• Clinical research services
• Biomanufacturing services
• Program management services

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Federal Government IDIQ Contracts: CAMRIS generates revenue through multiple indefinite delivery indefinite quantity (IDIQ) contract vehicles including Defense Health Agency OMNIBUS IV, GSA Multiple Award Schedule (MAS), OASIS+ unrestricted, and NIH/NIAID Professional, Scientific and Technical Support Services. Revenue is earned by competing for and delivering task orders under these pre-negotiated government contract vehicles for research, development, and program management services.
2. Pilot Bioproduction Facility (PBF) CDMO Services: Contract development and manufacturing organization (CDMO) services for Walter Reed Army Institute of Research, generating incremental contract revenue through interagency and private sector partnerships. Supports mRNA vaccines, monoclonal antibodies, viral vectors, and microbial biologics manufacturing.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

CAMRIS International provides adaptive professional and technical services to federal government agencies across military health and research, clinical and life sciences, and strategic program management. The company delivers biomedical research, laboratory services (BSL-2/3/3AG/4), biomanufacturing CDMO services, vaccine and clinical trial support, and grants/operations management through pre-negotiated IDIQ contract vehicles. CAMRIS is a wholly-owned subsidiary of the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) and serves DoD, DHA, NIH, and NIAID customers.

Product overview

CAMRIS International, Inc. is an adaptive solutions provider delivering professional services to federal government agencies in military health and research, clinical and life sciences, and strategic management and operations. The company operates through two primary divisions—Military Health & Research and Clinical & Life Sciences—supported by a portfolio of nine service areas: Military Operational Medicine Research, Clinical and Rehabilitative Medicine, Military Population Health, Infectious Diseases, Laboratory Services, Specialized Scientific Research and Veterinary Services, Vaccine & Immunological Research and Clinical Trials, Operations & Research Management, and Grants Management. CAMRIS provides research and program management expertise, technical talent, and compliance infrastructure to accelerate R&D and deliver results-based programs for government customers including DoD and NIH agencies.

Differentiator

Problem solved

Functional benefit

Products and services

• Military Operational Medicine Research Conducts biomedical research to deliver products and solutions for warfighters throughout the deployment cycle, including design, development, testing, and evaluation of novel physiological, biomedical, and technological countermeasures.
• Clinical and Rehabilitative Medicine Provides clinical, biomedical, engineering, and genomic research to deliver materials, knowledge products, and novel rehabilitative medicine solutions for injury prevention and restoration of health and wellness for service members.
• Military Population Health Supports force health protection and health promotion research, with teams of epidemiologists and public health experts addressing factors such as PTSD, TBI, obesity, and substance abuse to enhance military readiness.
• Infectious Diseases Research Works alongside military researchers to provide surveillance, outbreak detection, and rapid point-of-care infectious disease identification device development for warfighter protection against enteric, respiratory, and vector-borne diseases.
• Laboratory Services Provides advanced analytical tools and techniques including flow cytometry, fluorescence imaging, microscopy, quantitative PCR, and spectroscopic techniques in BSL-1 through BSL-4 laboratories for infectious and immunologic disease research.
• Specialized Scientific Research and Veterinary Services Offers computational systems biology, bioinformatics approaches, and preclinical expertise including veterinary sciences support in ABSL-2, -3, and -4 environments for testing candidate therapeutics.
• Vaccine and Immunological Research and Clinical Trials Delivers clinical trials expertise for transitioning candidate therapeutics from lab and animal models into clinical testing, with experience in over 60 infectious diseases and Phase I-IV clinical trial execution.
• Operations and Research Management Provides programmatic and administrative support including program management, regulatory affairs, financial planning, IT management, facilities management, and strategic planning for complex biomedical research programs.
• Grants Management Assists with identifying funding opportunities, planning and executing agreements, developing financial requirements, technical writing, and preparing solicitation-compliant documents for NIH, DHA, and private organizations.
• Pilot Bioproduction Facility (PBF) CDMO Services Contract development and manufacturing organization services at the $90M, 10-year government Pilot Bioproduction Facility at Walter Reed Army Institute of Research, providing biomanufacturing capabilities across mRNA vaccines, monoclonal antibodies, viral vectors, and microbial biologics platforms.

Quantifiable outcome

• Generated more than $20M in incremental contract revenue through interagency and private sector partnerships at the PBF
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Naval Health Research Center (NHRC)coreStrategic or Co-development Partner · 7 May 2026CAMRIS supported NHRC as it contributed critical laboratory capabilities to NASA's historic Artemis II mission and AVATAR investigation. CAMRIS personnel helped ensure NHRC's laboratories were ready to receive, process, and analyze the specialized payload for astronaut health research.
• World Vaccine CongressminorGTM or Marketing Partner · 30 March 2026CAMRIS team members actively participated in the 26th World Vaccine Congress (March 30-April 2, 2026) in Washington, DC. Senior Scientist Dr. Jennifer Grossman served as Chair of the Manufacturing Innovations and Processes session, and CAMRIS presented a poster on biomanufacturing capabilities.
• Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)coreStrategic or Co-development PartnerHJF is CAMRIS's parent company. CAMRIS is an HJF company, with HJF being a foundation dedicated to advancing military medicine. CAMRIS leverages this relationship for ethics resources and hotline support.
• National Institute of Allergy and Infectious Diseases (NIAID) - Vaccine Research CentercoreStrategic or Co-development PartnerCAMRIS biologists support the Vaccine Immunology Program's Automation Group at NIAID VRC, conducting high-throughput immunoassays, assay qualification, and laboratory automation for clinical trials of vaccines and antibody-based products targeting infectious diseases of global public health importance.
• Walter Reed Army Institute of Research (WRAIR)coreStrategic or Co-development PartnerCAMRIS manages the $90M Pilot Bioproduction Facility (PBF) at WRAIR, providing biomanufacturing capabilities across mRNA vaccines, monoclonal antibodies, viral vectors, and microbial biologics platforms. The PBF serves as a strategic national asset for pandemic preparedness and defense biomedical manufacturing.
• Naval Medical Research Center (NMRC)coreStrategic or Co-development PartnerCAMRIS has conducted malaria antigen discovery work for NMRC since 2011, led by Dr. João Aguiar. The partnership has resulted in a patent for anti-malaria antigens (US 10,195,260B2) with exceptional protection levels in pre-clinical research.
• Naval Medical Research Unit 6 Perú (NAMRU-6)minorStrategic or Co-development PartnerCAMRIS conducts research on epidemiology, ecology, and social and economic impacts of malaria under the Field Research in Infectious and Emerging Disease (FRIED) program for NAMRU-6.
• Walter Reed Army Institute of Research (WRAIR)coreStrategic or Co-development PartnerCAMRIS biologist Rachel Kazmierski's first job post-graduation was at WRAIR, where she conducted Shigella vaccine research for the U.S. Army, finding her passion for immunology and vaccine research that led to her current position.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Noblis:
• Battelle Memorial Institute: Nonprofit federal R&D organization operating BSL-3/4 labs and biomanufacturing capabilities for DoD, NIH, and BARDA — a comparable operating model and customer base to CAMRIS's clinical and life sciences business.
• MRIGlobal: Independent nonprofit scientific research organization providing infectious disease, CBRN, and laboratory services to federal agencies — directly comparable in mission, BSL lab operations, and federal contract model.

Broad incumbents

• Leidos: Large federal services prime with a significant biomedical, military health, and infectious disease portfolio that competes with CAMRIS on DHA OMNIBUS and OASIS+ task orders.
• SAIC: Federal R&D and engineering services prime with overlapping biomedical, defense health, and IDIQ contract work that directly competes with CAMRIS's federal services portfolio.
• Emergent BioSolutions: Public biodefense CDMO and vaccine developer — Brad Sepp previously held a senior role there — and a peer in CDMO operations and biomanufacturing capability sets that overlap with CAMRIS's PBF franchise.
• Booz Allen Hamilton: Federal consulting and program management prime competing for management, advisory, and scientific support work on GSA MAS and OASIS+ task orders alongside CAMRIS.
• CACI International: Federal IT and R&D services prime with DoD biomedical and DHA-adjacent work that overlaps with CAMRIS's professional and technical services portfolio.

Others

• Henry M. Jackson Foundation (HJF): Parent organization of CAMRIS; a nonprofit foundation supporting military medical research with overlapping DoD biomedical programs and shared customer relationships.

Emerging players

• Lonza Biologics: Global CDMO where Brad Sepp previously led GMP automation and brownfield relocation work — overlapping biomanufacturing and vaccine platform expertise with CAMRIS's PBF operation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/camris
• LinkedInlinkedin.com/company/camris-international-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAMRIS International, Inc.